Essential phospholipids for people with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Essential phospholipids for people with non-alcoholic fatty liver disease

Published:2019-04-03 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Varganova Daria L¹²³,Pavlov Chavdar S²³⁴,Casazza Giovanni⁵,Nikolova Dimitrinka³,Gluud Christian³

Affiliation:

1. Ulyanovsk Regional Clinical Hospital; Department of Gastroenterology; International 3 Ulyanovsk Russian Federation 432063

2. Center for Evidence-Based Medicine; 'Sechenov' First Moscow State Medical University; Pogodinskaya 1 Moscow Russian Federation 119991

3. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Sjaelland Denmark DK-2100

4. Kazan Federal University; 18 Kremlyovskaya Kazan Russian Federation 420008

5. Università degli Studi di Milano; Dipartimento di Scienze Biomediche e Cliniche "L. Sacco"; via GB Grassi 74 Milan Italy 20157

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013301/epdf/full

Reference88 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology (Baltimore, Md.),2018

2. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk;Ballestri;Advances in Therapy,2017

3. GRADE guidelines: 3. Rating the quality of evidence;Balshem;Journal of Clinical Epidemiology,2011

4. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study;Bedogni;Hepatology (Baltimore, Md.),2005

5. Operating characteristics of a rank correlation test for publication bias;Begg;Biometrics,1994

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial;Trials;2024-06-11

2. Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research;Meditsinskiy sovet = Medical Council;2024-04-18

3. Phospholipid-supplemented diet impacts on growth, blood metrics, reproductive indices, and fatty acid profiles of Pangasianodon hypopthalmus;Aquaculture Reports;2023-12

4. Polyenylphosphatidylcholine as bioactive excipient in tablets for the treatment of liver fibrosis;International Journal of Pharmaceutics;2023-11

5. Tracking matricellular protein SPARC in extracellular vesicles as a non-destructive method to evaluate lipid-based antifibrotic treatments;Communications Biology;2022-10-30